Programmable evolution of optogenetic systems
Programmable evolution of optogenetic systems
批准号:
10480900
负责人:
Todd P Coleman
金额:
$19.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-15 至 2024-08-31
关键词:
BiliverdineBindingBiochemicalBiological ProcessBiologyBlindnessCell ShapeCellsChemicalsDNA LibraryDarknessDiseaseDissectionEngineeringEnzymesEvolutionFluorescenceFutureGene ActivationGene Expression ProfilingGenesGrowthIn VitroIndividualKineticsLightMalignant NeoplasmsMammalian CellMass Spectrum AnalysisMeasuresMethodsModificationMutagenesisMutateOpticsOrganellesPhotophobiaPhytochromePlantsProductionPropertyProteinsPublishingResolutionSignal TransductionSystemTherapeuticTissuesWorkYeastschromophoredesignimprovedin vivoinsightlight intensityminimally invasivemutantoptical sensoroptogeneticsphyA phytochromephyB phytochromepressureprogramssensorspatiotemporalsynthetic constructtooltrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary: The ability to use light to control biological processes has enabled the careful
dissection of biology and could be developed into future treatments for blindness, cancer, and many
other diseases. Systems that respond to red to near-infrared (NIR) light are particularly useful because
those wavelengths efficiently penetrate tissue, but these systems can be greatly improved by
engineering them to efficiently bind endogenous chromophores or to be more sensitive to light. By
using a new continuous evolution system, OrthoRep, we will evolve the Phytochrome B (PhyB)
optogenetic tool to use biliverdin (which is present in every cell) as a chromophore and evolve versions
that are activated by different wavelengths of NIR light. This will be accomplished by modifying the
Automated Continuous Evolution (ACE) that can automatically apply evolutionary pressure as the gene
of the optogenetic tool continuously mutates. Because PhyB will respond to light by activating a gene
essential for survival, it will be possible to evolve the activation wavelength, the amount of light that is
required to activate the gene, and the level of the activation once illuminated. Evolved PhyB mutants
that have useful properties will be validated/characterized biochemically and for controlling genes in
mammalian cells. The resulting optogenetic tools will enable new opportunities for in vivo optogenetics
and the modified ACE can be used to develop many other types of optogenetic tools, optical sensors,
and more.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Traveling waves in neocortical circuits: Mechanisms, computational roles in sensory processing, and impact on sensory perception
-
批准号:10655101
-
项目类别:
-
资助金额:$247.84万
-
财政年份:2023
-
负责人:Todd P Coleman
-
依托单位:
Programmable evolution of optogenetic systems
-
批准号:10318056
-
项目类别:
-
资助金额:$23.61万
-
财政年份:2021
-
负责人:Todd P Coleman
-
依托单位:
Programmable evolution of optogenetic systems
-
批准号:10623650
-
项目类别:
-
资助金额:$2.29万
-
财政年份:2021
-
负责人:Todd P Coleman
-
依托单位:
Inverse Methods for Spatiotemporal Characterization of Gastric Electrical Activity and its Association with Upper GI Symptoms from Cutaneous Multi-electrode Recordings
-
批准号:10196836
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2021
-
负责人:Todd P Coleman
-
依托单位:
iGLAMOUR Study: Innovations in Glaucoma Adherence and monitoring Of Under-Represented minorities
-
批准号:10330002
-
项目类别:
-
资助金额:$52.64万
-
财政年份:2021
-
负责人:Todd P Coleman
-
依托单位:
Inverse Methods for Spatiotemporal Characterization of Gastric Electrical Activity and its Association with Upper GI Symptoms from Cutaneous Multi-electrode Recordings
-
批准号:10394942
-
项目类别:
-
资助金额:$7.9万
-
财政年份:2021
-
负责人:Todd P Coleman
-
依托单位:
iGLAMOUR Study: Innovations in Glaucoma Adherence and monitoring Of Under-Represented minorities
-
批准号:10549804
-
项目类别:
-
资助金额:$52.96万
-
财政年份:2021
-
负责人:Todd P Coleman
-
依托单位:
A Novel Model System for Restoring Hearing in vivo
-
批准号:10224166
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2020
-
负责人:Todd P Coleman
-
依托单位:
A Novel Model System for Restoring Hearing in vivo
-
批准号:10058225
-
项目类别:
-
资助金额:$28.55万
-
财政年份:2020
-
负责人:Todd P Coleman
-
依托单位:
SCH: Interface Monitoring System to Promote Residual Limb Health
-
批准号:8930987
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2014
-
负责人:Todd P Coleman
-
依托单位:
SCH: Interface Monitoring System to Promote Residual Limb Health
-
批准号:8788318
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2014
-
负责人:Todd P Coleman
-
依托单位:
SCH: Interface Monitoring System to Promote Residual Limb Health
-
批准号:9313641
-
项目类别:
-
资助金额:$34.79万
-
财政年份:2014
-
负责人:Todd P Coleman
-
依托单位:
SCH: Interface Monitoring System to Promote Residual Limb Health
-
批准号:9071412
-
项目类别:
-
资助金额:$36.02万
-
财政年份:2014
-
负责人:Todd P Coleman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: